Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus
Gulam H. Syed, Aleem Siddiqui – 2 December 2011 – Hepatitis C virus (HCV) relies on host lipid metabolic pathways for its replication, assembly, secretion, and entry. HCV induces de novo lipogenesis, inhibits β‐oxidation, and lipoprotein export resulting in a lipid‐enriched cellular environment critical for its proliferation. We investigated the effects of a hypolipidemic agent, nordihydroguaiaretic acid (NDGA), on host lipid/fatty acid synthesis and HCV life cycle. NDGA negated the HCV‐induced alteration of host lipid homeostasis.